A Transcription Factor Signature Can Identify the CMS4 Subtype and Stratify the Prognostic Risk of Colorectal Cancer

A Transcription Factor Signature Can Identify the CMS4 Subtype and Stratify the Prognostic Risk of Colorectal Cancer

BackgroundColorectal cancer (CRC) is a heterogeneous disease, and current classification systems are insufficient for stratifying patients with different risks. This study aims to develop a generalized, individualized prognostic consensus molecular subtype (CMS)-transcription factors (TFs)-based sig...

Full description

Bibliographic Details
Main Authors: Min-Er Zhong, Ze-Ping Huang, Xun Wang, Du Cai, Cheng-Hang Li, Feng Gao, Xiao-Jian Wu, Wei Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
colorectal cancer
CMS4
transcription factors
prognosis
prediction
signature
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.902974/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.902974/full

Similar Items